Evidence map›Paper›PMID 40991272›Full record

ArticleJAMA psychiatry2025

Progression of Transdiagnostic Stages From Childhood to Young Adulthood.

Aswin Ratheesh, Yufan Chen, Dylan Hammond, Zoe Aitken, Jai Shah, Frank Iorfino, Jan Scott, Ian Hickie, Chris Davey, Andrew Chanen and 5 more

Abstract read
In one paragraph

Article in JAMA psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Aswin RatheeshDiscipline of Psychiatry and Mental Health, University of New South Wales, Sydney, New South Wales, Australia.
Yufan ChenDiscipline of Psychiatry and Mental Health, University of New South Wales, Sydney, New South Wales, Australia.
Dylan HammondCentre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Zoe AitkenMelbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
Jai ShahPrevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, Quebec, Canada.
Frank IorfinoBrain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Jan ScottBrain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Ian HickieBrain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Chris DaveyDepartment of Psychiatry, University of Melbourne, Melbourne, Victoria, Australia.
Andrew ChanenCentre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Michael BerkInstitute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Barwon Health, Geelong, Australia.
Patrick McGorryCentre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Steven MarwahaInstitute for Mental Health, University of Birmingham, UK and Birmingham and Solihull Mental Health NHS Trust, Birmingham, United Kingdom.
Andrew ThompsonCentre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.
Barnaby NelsonCentre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Transdiagnostic clinical staging models for mental disorders are receiving increased attention. However, their underlying assumptions are underresearched; for example, it is not clear whether the observed progression across stages occurs independently of preexisting risk factors. Objectives: To test the likelihood of progression from stage 0 (familial risk) in childhood to stage 1a (mild symptoms) in adolescence and subsequently to stage 1b (clinically significant symptoms) in young adulthood, accounting for confounders, and to explore potential mediators. Design, Setting, and Participants: This prospective cohort study included participants from the Avon Longitudinal Study of Parents and Children (ALSPAC). ALSPAC included pregnant women and their offspring residing in Avon, United Kingdom, between 1991 and 1992, with a proportion of offspring followed up into young adulthood. Eligible participants provided data on stage determinants and potential confounders from birth until age 24 years. Data were collected from 1991 to 2015 and analyzed from January 2002 to June 2025. Exposures: Exposures were clinical stages 0 and 1a in separate tests of association with stages 1a and 1b, respectively. Criteria for stage 0 were the presence of schizophrenia or severe depression in a first-degree relative. Criteria for stage 1a were the presence of 1 to 2 symptoms of depression, anxiety, or psychosis at ages 12 to 13 years. Main Outcomes and Measures: Outcomes were stage 1a in adolescence and stage 1b in young adulthood. Criteria for stage 1b were at least moderate symptoms of depression, anxiety, or psychosis, with associated functional impact at ages 18 to 24 years. Confounders were sex assigned at birth, obstetric risk, parental social class, ethnicity, family adversity, temperament, early life events, and neurocognition, measured in childhood. Results: Among those with complete data at all 3 time points (1375 participants; weighted, 7342), 796 participants (57.9%; weighted, 51.5%) were female and 579 (42.1%; weighted, 48.5%) were male. After adjusting for potential confounders, there was an association between stage 0 in childhood and stage 1a in adolescence (3860 participants; weighted, 7388 participants; odds ratio [OR], 1.65, 95% CI, 1.30-2.11) and between stage 1a in adolescence and stage 1b in young adulthood (1661 participants; weighted, 7466 participants; OR, 2.07; 95% CI, 1.07-4.01). Level of neuroticism in adolescence mediated 18% of the association between stage 1a in adolescence and stage 1b in young adulthood. Conclusions and Relevance: In this cohort study, young people with mental health problems meeting criteria for early clinical stages were at heightened risk of developing subsequent stages, independent of early life risk factors. This study supports the assumption of progression underlying clinical staging models for mental disorders.

Indexed as

Anxiety DisordersDisease ProgressionPsychotic DisordersSchizophreniaAdolescentAdultChildFemaleHumansLongitudinal StudiesMaleProspective StudiesRisk FactorsUnited KingdomYoung Adult

Identifiers

PMID40991272
PMCPMC12461601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.